Vertaling van "colloquium on blood safety and " (Nederlands → Frans) :

In de EU werd op het ‘Adare Colloquium on Blood Safety and Self-sufficiency’ in 1996 besloten dat ALT screening overbodig geworden was.
Dans l’UE, il a été décidé à l’‘Adare Colloquium on Blood Safety and Self-sufficiency’, en 1996, que le dépistage ALT était devenu superflu.

‐ Goodrich RP, Edrich RA, Goodrich LL, Scott CA, Manica KJ, Hlavinka DJ, et al. The Antiviral and Antibacterial Properties of Riboflavin and Light: Applications To Blood Safety and Transfusion Medicine.
and Antibacterial Properties of Riboflavin and Light: Applications To Blood Safety and Transfusion Medicine.

7.3 RESEARCH QUESTIONS IMPROVING OPTIMAL BLOOD SAFETY______________________________34
7.3 RESEARCH QUESTIONS IMPROVING OPTIMAL BLOOD SAFETY______________________________35

Meeting of the Advisory Committee on Blood Safety & Availability (ACSBA), 30 May 2008: Clinical Significance of Red Cell Age in Transfusions; 2008 [accessed 2008 June 17].
Meeting of the Advisory Committee on Blood Safety & Availability (ACBSA), 30 May 2008: Clinical Significance of Red Cell Age in Transfusions; 2008 [accessed 2008 June 17].

Nucleic acid sequence based amplification Nucleic Acid Amplification Testing Non-heart beating donors National Institute for Biological Standards and Control Optische densiteit Occupational Safety and Health Administration Perazijnzuur Phosphate buffered saline Polymerase chain reaction Perazijnzuur ethanol sterilisatie Positive predictive value Positief predictieve waarde Polyvinyl-pyrrolidon Povidone-iodine Quaternaire ammoniumverbindingen Radio-immunoprecipitatie test Ribonucleic acid Ribonuclease H Respiratoir syncytiaal virus Reverse transcriptase Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Median tissue culture infective dose Transcription-mediated amplification Tumor necrosis factor United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Verenigde Staten Werkgroep infectiepreventie West Nile virus World Health Organization
Morbidity and mortalility weekly report Nucleic acid sequence based amplification Nucleic Acid Amplification Testing National Institute for Biological Standards and Control Occupational Safety and Health Administration Phosphate buffered saline ou tampon phosphate Polymerase chain reaction Stérilisation acide peracétique-éthanol Positive predictive value Polyvinyl-pyrrolidon Povidone-iodine Dérivés de l’ammonium quaternaire Ribonuclease H Reverse transcriptase ou transcriptase inverse Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Syndrome d’immunodéficience acquise Median tissue culture infective dose Test d’immunofluorescence indirecte Transcription-mediated amplification Tumor necrosis factor Test de radio-immunoprécipitation United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Valeur prédictive positive Virus respiratoire syncytial Etats-Unis Werkgroep infectiepreventie ou groupe de travail sur la prévention des infections West Nile virus World Health Organization

haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.
haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.

The mission of the Vigilance department is to supervise the safety of medicines for users (pharmacovigilance), blood and labile blood derivatives (haemovigilance) and tissues and cells (biovigilance).
The mission of the Vigilance department is to supervise the safety of medicines for users (pharmacovigilance), blood and labile blood derivatives (haemovigilance) and tissues and cells (biovigilance).

serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about
serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about

Safety of Blood Components Meeting, PEI, 21/03/03.
of Blood Components Meeting, PEI, 21/03/03.

Er kan steeds advies gevraagd worden aan het Departement Goed Gebruik van het Geneesmiddel (BUM) van het FAGG en aan de leden van Efficacy Working Party (EWP), Safety Working Party (SWP), Biosimilar Medicinal Products Working Party (BMWP), Blood Working Party (BWP) en Quality Working Party (QWP).
On peut toujours demander un avis au Département Bon Usage du Médicament (BUM) de l’AFMPS et aux membres des groupes suivants : Efficacy Working Party (EWP), Safety Working Party (SWP), Biosimilar Medicinal Products Working Party (BMWP), Blood Working Party (BWP) et Quality Working Party (QWP).